Adam Smigielski Clinical stage company BioVie ( NASDAQ: BIVI ) priced public offering of 1.96M shares and warrants. The warrants will have an exercise price of $1.
53 per share and will be immediately exercisable upon issuance for a period of five years following the date of.
